Arovella Therapeutics LimitedASX: ALA

Corporate Governance Statement

· Issued by Arovella Therapeutics Limited via ASX

Filed with ASX ·

Page 1 Corporate Governance Statement 30 June 2026 This Corporate Governance Statement of Arovella Therapeutics Limited (“Arovella” or “the Company”) is prepared in accordance with ASX Listing Rule 4.10.3. It is for the financial year ended 30 June 2026 and is accurate and...

View Attachment

6ix hasn’t read this filing yet.

Arovella Therapeutics Limited on 6ix

Earlier from Arovella Therapeutics

Later from Arovella Therapeutics

All Arovella Therapeutics news releases